Skip to main content

Table 4 Associations between gender-specific age categories and total- and domain specific health-related quality of life (HRQL), with consideration to severe symptoms, and time since worst reaction

From: Food allergy-related concerns during the transition to self-management

 

Overall HRQL

AADR

EI

RAE

Mean

βa

95% CI

Mean

βa

95% CI

Mean

βa

95% CI

Mean

βa

95% CI

Severe symptoms

 Males (years)

 < 18

4.82

Referent

 

5.14

Referent

 

4.39

Referent

 

4.38

Referent

 

  18–39

5.69

0.62

− 0.15; 1.38

6.15 †

0.80

0.01; 1.59

5.25

0.61

− 0.27; 1.50

4.71

− 0.11

− 1.40; 1.17

  40+

4.94

0.24

− 0.64; 1.12

5.43

0.36

− 0.56; 1.27

4.65

0.40

− 0.62; 1.43

3.55

− 0.49

− 1.97; 1.00

 Females (years)

  < 18

5.56

Referent

 

5.75

Referent

 

5.63

Referent

 

4.68

Referent

 

  18–39

5.19

− 0.34

− 1.05; 0.38

5.64

− 0.11

− 0.89; 0.67

4.69 †

− 0.87

− 1.75, 0.00

4.45

− 0.21

− 1.39; 0.96

  40+

5.39

− 0.19

− 0.90; 0.52

5.84

0.01

− 0.77; 0.79

4.67

− 0.96

− 1.83; − 0.09

5.28

0.66

− 0.50; 1.82

0–3 years since worst reaction

 Males (years)

  < 18

5.18

Referent

 

5.52

Referent

 

4.54

Referent

 

5.13

Referent

 

  18–39

6.40 ‡

1.31

0.33; 2.30

6.85 †

1.39

0.24; 2.55

6.05 †

1.61

0.46; 2.76

5.30

0.38

− 1.25; 2.00

  40+

4.98

− 0.08

− 1.11; 0.94

5.60

0.08

− 1.12; 1.28

4.58

0.36

− 0.83; 1.55

3.33

− 1.55

− 3.24; 0.14

 Females (years)

  < 18

5.62

Referent

 

5.80

Referent

 

5.73

Referent

 

4.70

Referent

 

  18–39

4.54

− 0.11

− 0.82; 0.60

5.91

0.12

− 0.66; 0.91

4.96

− 0.63

− 1.43; 0.16

4.50

− 0.02

− 1.43; 1.40

  40+

5.30

− 0.20

− 0.92; 0.52

5.83

0.78

− 0.72; 0.87

4.52 †

− 0.97

− 1.78; − 1.67

4.75

0.22

− 1.21; 1.66

4+ years since worst reaction

 Males (years)

  < 18

4.23

Referent

 

4.53

Referent

 

4.05

Referent

 

3.40

Referent

 

  18–39

5.36

0.89

− 0.04; 1.82

5.84 ‡

1.28

0.36; 2.19

4.85

0.35

− 0.90; 1.61

4.50

0.43

− 1.22; 2.08

  40+

4.68

1.13

− 0.39; 2.65

5.39 †

1.75

0.26; 3.24

3.60

− 0.08

− 2.12; 1.95

4.10

1.22

− 1.47; 3.91

 Females (years)

 < 18

4.89

Referent

 

5.29

Referent

 

4.61

Referent

 

3.86

Referent

 

  18–39

4.94

− 0.37

− 1.61; 0.88

5.40

− 0.23

− 1.61; 1.16

4.47

− 0.63

− 2.17; 0.90

4.11

− 0.33

− 2.14; 1.48

  40+

5.54

0.29

− 0.91; 1.49

6.03

0.42

− 0.94; 1.78

4.74

− 0.32

− 1.80; 1.16

5.59

1.39

− 0.36; 3.13

  1. Italic denotes statistically significant results
  2. HRQL is on a scale from 1 to 7, where 1 = best possible HRQL, and 7 = worst possible HRQL
  3. HRQL health-related quality of life, AADR allergen avoidance and dietary restrictions, EI emotional impact, RAE risk of accidental exposure
  4. †p < 0.05
  5. ‡p < 0.01
  6. aRepresent mean difference in outcome compared to the reference group. Calculated by linear regression, adjusted for number of food allergies and prescription of an epinephrine autoinjector
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us